1 year return (CAGR)
4.28%
Maze Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
MAZE
31.69
+0.62 (+2.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.76B
Price/Sales
88.02
Ent value
1.64B
Price/Book
3.88
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 31.18 |
| Daily high | 32.01 |
| Daily low | 30.88 |
| Daily Volume | 625K |
| All-time high | 51.84 |
| 1y analyst estimate | 61.50 |
| Beta | - |
| EPS (TTM) | -2.26 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MAZE | S&P500 | |
| Current price drop from All-time high | -38.86% | -1.21% |
| Highest price drop | -56.81% | -56.47% |
| Date of highest drop | 21 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -27.27% | -10.65% |
| Avg time to new high | 8 days | 12 days |
| Max time to new high | 159 days | 1805 days |
News
